EDSA (Edesa Biotech, Inc. Common Shares)
Insider Trading Activity
Every open-market purchase and sale reported by EDSA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2026-08-04 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2026-07-02 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2026-06-16 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2026-06-01 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2026-05-29 | Peter J. Weiler | Chief Financial Officer | A | — | — |
| 2026-05-29 | Sean Arthur MacDonald | Director | A | — | — |
| 2026-05-29 | Charles V Olson | Director | A | — | — |
| 2026-05-29 | Da David Liu | Director | A | — | — |
| 2026-05-29 | Patrick Marshall | Director | A | — | — |
| 2026-05-29 | Joan Chypyha | Director | A | — | — |
| 2026-05-29 | Carlo Sistilli | Director | A | — | — |
| 2026-05-29 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2026-05-29 | Michael J Brooks | President | A | — | — |
| 2026-05-01 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2026-04-10 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2026-03-11 | Michael J Brooks | President | Buy | — | — |
| 2026-03-10 | Pardeep Nijhawan | Chief Executive Officer | Buy | — | — |
| 2026-03-06 | Pardeep Nijhawan | Chief Executive Officer | Buy | — | — |
| 2026-03-05 | Pardeep Nijhawan | Chief Executive Officer | Buy | — | — |
| 2026-03-04 | Pardeep Nijhawan | Chief Executive Officer | Buy | — | — |
| 2026-03-03 | Pardeep Nijhawan | Chief Executive Officer | Buy | — | — |
| 2026-03-02 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2026-03-02 | Pardeep Nijhawan | Chief Executive Officer | MIXED | — | — |
| 2026-02-02 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2026-01-05 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2025-12-02 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2025-11-06 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2025-10-03 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2025-09-12 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2025-08-04 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2025-07-02 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2025-06-02 | Peter J. Weiler | Chief Financial Officer | A | — | — |
| 2025-06-02 | Da David Liu | Director | A | — | — |
| 2025-06-02 | Michael J Brooks | President | A | — | — |
| 2025-06-02 | Sean Arthur MacDonald | Director | A | — | — |
| 2025-06-02 | Carlo Sistilli | Director | A | — | — |
| 2025-06-02 | Joan Chypyha | Director | A | — | — |
| 2025-06-02 | Patrick Marshall | Director | A | — | — |
| 2025-06-02 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2025-06-02 | Charles V Olson | Director | A | — | — |
| 2025-05-06 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2025-04-03 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2025-03-03 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2025-02-14 | Carlo Sistilli | Director | A | — | — |
| 2025-02-14 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2025-02-14 | Patrick Marshall | Director | A | — | — |
| 2025-02-04 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2025-01-06 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| 2024-12-03 | Pardeep Nijhawan | Chief Executive Officer | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chief Executive Officer | 931,113 | — |
| — | President | 291,479 | — |
| — | Director | 261,867 | — |
| — | Director | 252,083 | — |
| — | Chief Executive Officer | 138,077 | — |
| — | Chief Financial Officer | 129,609 | — |
| — | Director | 72,131 | — |
| — | Director | 49,939 | — |
| — | Director | 41,054 | — |
| — | Director | 30,029 | — |
| — | Director | 30,000 | — |
| — | Director | 24,501 | — |
| — | Chief Financial Officer | 2,486 | — |
| — | Director | 1,827 | — |
| — | Chief Financial Officer | 1,531 | — |
| — | Director | 522 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the EDSA quote page; the site-wide leaderboard is on the insider transactions hub.